Caricamento...
Chemotherapy Tolerance and Oncologic Outcomes in Patients With Colorectal Cancer With and Without Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is a risk factor for colorectal cancer (CRC). We evaluated chemotherapy tolerance and oncologic outcomes from the medical records of patients with CRC with and without IBD. In this series, patients with CRC with IBD experienced more treatment alterations than those w...
Salvato in:
| Pubblicato in: | Clin Colorectal Cancer |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6009836/ https://ncbi.nlm.nih.gov/pubmed/27742264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clcc.2016.09.005 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|